Wolfgang H. Oertel

44.5k total citations · 8 hit papers
292 papers, 23.4k citations indexed

About

Wolfgang H. Oertel is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Wolfgang H. Oertel has authored 292 papers receiving a total of 23.4k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Neurology, 74 papers in Cellular and Molecular Neuroscience and 46 papers in Cognitive Neuroscience. Recurrent topics in Wolfgang H. Oertel's work include Parkinson's Disease Mechanisms and Treatments (205 papers), Neurological disorders and treatments (121 papers) and Botulinum Toxin and Related Neurological Disorders (34 papers). Wolfgang H. Oertel is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (205 papers), Neurological disorders and treatments (121 papers) and Botulinum Toxin and Related Neurological Disorders (34 papers). Wolfgang H. Oertel collaborates with scholars based in Germany, United States and United Kingdom. Wolfgang H. Oertel's co-authors include Werner Poewe, Günther Deuschl, Ronald B. Postuma, Günter U. Höglinger, Daniela Berg, C. Warren Olanow, Anthony E. Lang, Thomas Gasser, José Á. Obeso and Kenneth Marek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Wolfgang H. Oertel

290 papers receiving 23.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MDS clinical diagnostic criteria for Parkinson's disease

2015 4.8k citations Ronald B. Postuma, Daniela Berg et al. Movement Disorders profile →
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

2005 900 citations Alexander Gerhard, Federico Turkheimer et al. profile →
MDS research criteria for prodromal Parkinson's disease

2015 876 citations Daniela Berg, Ronald B. Postuma et al. Movement Disorders profile →
Dopamine depletion impairs precursor cell proliferation in Parkinson disease

2004 752 citations Günter U. Höglinger, Wolfgang H. Oertel et al. profile →
The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument

2007 728 citations Geert Mayer, Jens Carsten Möller et al. Movement Disorders profile →
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease

2012 433 citations Ronald B. Postuma, Wolfgang H. Oertel et al. Movement Disorders profile →
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

2017 405 citations Friederike Sixel‐Döring, Annette Janzen et al. Movement Disorders profile →
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential

2023 152 citations Martin T. Henrich, Wolfgang H. Oertel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfgang H. Oertel Germany	71	15.9k	6.0k	3.6k	3.5k	3.1k	292	23.4k
Niall Quinn United Kingdom	93	24.9k 1.6×	12.0k 2.0×	3.1k 0.9×	4.5k 1.3×	4.9k 1.6×	326	31.7k
Caroline M. Tanner United States	73	16.5k 1.0×	5.7k 0.9×	2.4k 0.7×	3.7k 1.1×	2.9k 0.9×	254	24.0k
Christopher G. Goetz United States	96	27.4k 1.7×	8.6k 1.4×	6.9k 1.9×	3.5k 1.0×	3.3k 1.1×	431	36.6k
José Á. Obeso Spain	78	21.1k 1.3×	10.8k 1.8×	5.3k 1.5×	3.1k 0.9×	3.8k 1.2×	308	29.1k
Udo Rüb Germany	52	12.6k 0.8×	7.3k 1.2×	2.7k 0.7×	4.9k 1.4×	3.6k 1.2×	103	20.9k
Olivier Rascol France	86	20.8k 1.3×	7.7k 1.3×	4.7k 1.3×	2.5k 0.7×	3.0k 0.9×	434	27.5k
Eduardo Tolosa Spain	84	19.8k 1.2×	6.5k 1.1×	4.7k 1.3×	2.9k 0.8×	3.6k 1.1×	386	26.6k
Gregor K. Wenning Austria	84	23.4k 1.5×	10.4k 1.7×	2.5k 0.7×	3.8k 1.1×	5.9k 1.9×	418	29.6k
Daniela Berg Germany	83	19.8k 1.2×	6.8k 1.1×	2.9k 0.8×	5.7k 1.6×	4.2k 1.3×	533	29.2k
J. Eric Ahlskog United States	80	13.3k 0.8×	5.2k 0.9×	2.4k 0.7×	1.9k 0.5×	2.2k 0.7×	279	19.9k

Countries citing papers authored by Wolfgang H. Oertel

Since Specialization

Citations

This map shows the geographic impact of Wolfgang H. Oertel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang H. Oertel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang H. Oertel more than expected).

Fields of papers citing papers by Wolfgang H. Oertel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang H. Oertel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang H. Oertel. The network helps show where Wolfgang H. Oertel may publish in the future.

Co-authorship network of co-authors of Wolfgang H. Oertel

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang H. Oertel. A scholar is included among the top collaborators of Wolfgang H. Oertel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang H. Oertel. Wolfgang H. Oertel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oertel, Wolfgang H., Annette Janzen, Martin T. Henrich, et al.. (2024). Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern—case reports. Nature Communications. 15(1). 7619–7619. 11 indexed citations

Meles, Sanne K., Remco J. Renken, Fransje E. Reesink, et al.. (2022). FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder. Computer Methods and Programs in Biomedicine. 225. 107042–107042. 18 indexed citations

Malabirade, Antoine, Javier Ramiro‐Garcia, Janine Habier, et al.. (2021). Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics. ISME Communications. 1(1). 82–82. 5 indexed citations

Henrich, Martin T., Fanni F. Geibl, Lakshminarasimhan Harini, et al.. (2020). Determinants of seeding and spreading of α-synuclein pathology in the brain. Science Advances. 6(46). 66 indexed citations

Cesari, Matteo, Julie Anja Engelhard Christensen, A N Olesen, et al.. (2018). Comparison of computerized methods for rapid eye movement sleep without atonia detection. SLEEP. 41(10). 32 indexed citations

Oertel, Wolfgang H. & Jörg B. Schulz. (2016). Current and experimental treatments of Parkinson disease: A guide for neuroscientists. Journal of Neurochemistry. 139(S1). 325–337. 265 indexed citations

Schrempf, Wiebke, István Katona, Imis Dogan, et al.. (2016). Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism & Related Disorders. 29. 10–16. 23 indexed citations

Postuma, Ronald B., Daniela Berg, Matthew Stern, et al.. (2015). MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders. 30(12). 1591–1601. 4841 indexed citations breakdown →

Berg, Daniela, Ronald B. Postuma, Bastiaan R. Bloem, et al.. (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders. 29(4). 454–462. 341 indexed citations

10.

Kobylecki, Christopher, Serena J. Counsell, Nicole Cabanel, et al.. (2013). Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes. Parkinsonism & Related Disorders. 19(5). 527–532. 19 indexed citations

11.

Nowak, Marcin, Adam Strzelczyk, Philipp S. Reif, et al.. (2012). Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsy. Seizure. 21(3). 227–228. 40 indexed citations

12.

Carlsson, Thomas, Matthias Höllerhage, Candan Depboylu, et al.. (2011). Systemic administration of neuregulin‐1β₁ protects dopaminergic neurons in a mouse model of Parkinson’s disease. Journal of Neurochemistry. 117(6). 1066–1074. 63 indexed citations

13.

Dodel, Richard, B. Karthikeyan, Kathy Keyvani, et al.. (2011). Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease. PMC. 42 indexed citations

14.

Winter, Yaroslav, Sonja von Campenhausen, Klaus Seppi, et al.. (2009). Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study. Journal of Neurology. 257(4). 638–645. 53 indexed citations

15.

Herzog, Jan, Oliver Pogarell, Marcus O. Pinsker, et al.. (2008). Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Movement Disorders. 23(9). 1293–1296. 33 indexed citations

16.

Teepker, Michael, Veit Mylius, Anja Haag, et al.. (2008). Serum Concentrations of s100b and NSE in Migraine. Headache The Journal of Head and Face Pain. 49(2). 245–252. 47 indexed citations

17.

Wüllner, Ullrich, T. Schmitz‐Hübsch, Gisela Antony, et al.. (2007). Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. European Journal of Neurology. 14(12). 1405–1408. 69 indexed citations

18.

Höllerhage, Matthias, Marie‐Paule Muriel, Pierre Champy, et al.. (2007). Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons. Journal of Neuroscience. 27(29). 7827–7837. 170 indexed citations

19.

Giladi, Nir, Olivier Rascol, Daniel J. Brooks, et al.. (2004). Rasagiline treatment can improve freezing of gait in advanced Parkinson's disease; a prospective randomised double blind, placebo and entacapone controlled study.. Movement Disorders. 19. 17 indexed citations

20.

Oertel, Wolfgang H. & Niall Quinn. (1997). Parkinson's disease: drug therapy.. PubMed. 6(1). 89–108. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact